BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29

• Pharm Country

  Biotech Support Group LLC Release: Cites Cleanascite For Serum Diabetes Biomarkers

  February 5, 2016

   · 

  2 min read
• Pharm Country

  The Medicines Company Announces Clive Meanwell, MD, Phd, Chief Executive Officer, Is The Recipient Of The 2016 Dr. Sol J. Barer Award For Vision, Innovation And Leadership

  February 5, 2016

   · 

  3 min read
• Business

  Muscular Dystrophy Association To Collaborate With Catabasis Pharma On Development Of CAT-1004, A Potential Novel Oral Disease-Modifying Treatment For Duchenne Muscular Dystrophy

  February 5, 2016

   · 

  7 min read
• Pharm Country

  Tivorsan Pharmaceuticals, Inc. Closes Private Placement

  February 5, 2016

   · 

  4 min read
• Biotech Bay

  MyoKardia Publishes Article In Science Demonstrating That MYK-461 Prevents And Reverses Disease In Genetic Mouse Models Of Hypertrophic Cardiomyopathy

  February 5, 2016

   · 

  5 min read
• Genetown

  LabRoots, Inc. Release: Cell Signaling Technology Webinar Illuminates BioPlex Protein Interaction Network

  February 5, 2016

   · 

  3 min read
• Pharm Country

  22nd Century Group, Inc.'s Very Low Nicotine Cigarettes Identified As An Important Public Health Tool To Reduce Smoking Rates In New Zealand

  February 5, 2016

   · 

  4 min read
• Biotech Bay

  Medtronic’s iPro2 Professional CGM Shows Benefits For People With Type 2 Diabetes

  February 5, 2016

   · 

  3 min read
• Biotech Bay

  Thermo Fisher Scientific Release: High-Pressure Ion Chromatography System Delivers New Levels of Simplicity And Flexibilit

  February 5, 2016

   · 

  3 min read
• Policy

  FDA Acknowledges Receipt Of Resubmission Of Shire’s New Drug Application For Lifitegrast For Dry Eye Disease In Adults

  February 5, 2016

   · 

  10 min read